epithelial ovarian cancer market insights, epithelial ovarian cancer market growth, epithelial ovarian cancer market forecast, epithelial ovarian cancer market outlook, epithelial ovarian cancer market scope, epithelial ovarian cancer market trends
How much is the epithelial ovarian cancer market worth, and how is it expected to expand?
The epithelial ovarian cancer market size has grown rapidly in recent years. It will grow from $2.08 billion in 2024 to $2.42 billion in 2025 at a compound annual growth rate (CAGR) of 16.5%. The growth in the historic period can be attributed to increasing demand for personalized cancer treatments, rise in global healthcare expenditure, growing demand for minimally invasive surgeries, rising number of ovarian cancer survivors, rising demand for gene therapies, increasing demand for palliative care services.
The epithelial ovarian cancer market size is expected to see rapid growth in the next few years. It will grow to $4.41 billion in 2029 at a compound annual growth rate (CAGR) of 16.1%. The growth in the forecast period can be attributed to rising incidence of ovarian cancer, aging population, increased awareness of ovarian cancer, growth in research funding for cancer, increasing government initiatives to combat cancer. Major trends in the forecast period include technological advancements in medical imaging, introduction of new molecular diagnostic tools, collaborations between pharmaceutical companies, rapid adoption of AI and machine learning in diagnostics, and expanding use of robotic surgeries.
Get Your Free Sample of The Global Epithelial Ovarian Cancer Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20778&type=smp
Which industry factors have accelerated the epithelial ovarian cancer market’s expansion?
The increasing prevalence of ovarian cancer is expected to propel the growth of the epithelial ovarian cancer market going forward. Ovarian cancer is a cancer that starts in the ovaries, primarily affecting the epithelial cells that cover the surface of the ovaries. The increasing prevalence of ovarian cancer is primarily due to an aging population, improved awareness, and higher detection rates, along with genetic and lifestyle factors. Epithelial ovarian cancer treatment is required to address the most common and aggressive form of ovarian cancer, targeting malignant cells to improve survival rates and patient outcomes. For instance, in February 2024, according to the World Ovarian Cancer Coalition, a Canada-based non-profit organization, by 2050, the global number of women diagnosed with ovarian cancer is expected to increase by over 55%, reaching 503,448. Annual deaths from ovarian cancer are projected to rise to 350,956, reflecting a nearly 70% increase from 2022. Therefore, the increasing prevalence of ovarian cancer will drive the epithelial ovarian cancer market going forward.
What are the primary segments of the epithelial ovarian cancer market?
The epithelial ovarian cancer market covered in this report is segmented –
1) By Type Of Treatment: Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy, Surgery
2) By Drug Class: Platinum-based Chemotherapy Drugs, Poly(ADP-ribose) Polymerase Inhibitors, Bevacizumab, Chemotherapeutic Agents
3) By Stage Of Cancer: Early Stage, Advanced Stage
4) By Diagnosis Method: Imaging, Biopsy, Blood Tests
5) By End User: Hospitals, Clinics, Diagnostic Laboratories
Subsegments:
1) By Chemotherapy: Platinum-Based Chemotherapy, Non-Platinum Chemotherapy, Combination Chemotherapy
2) By Targeted Therapy: Monoclonal Antibodies, PARP Inhibitors, Angiogenesis Inhibitors, Other Targeted Agents
3) By Immunotherapy: Checkpoint Inhibitors, Cancer Vaccines, Adoptive T-Cell Therapy
4) By Hormonal Therapy: Selective Estrogen Receptor Modulators (SERMs), Aromatase Inhibitors, Progestins
5) By Surgery: Debulking Surgery, Oophorectomy, Hysterectomy, Other Surgical Procedures
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/epithelial-ovarian-cancer-global-market-report
Which firms are leading the epithelial ovarian cancer market?
Major companies operating in the epithelial ovarian cancer market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline plc, Eli Lilly and Company, Boehringer Ingelheim GmbH, Merck KGaA, Siemens Healthineers AG, Quest Diagnostics Incorporated, Eisai Co. Ltd., Genentech Inc., Qiagen N.V., Myriad Genetics Inc., Zymeworks Inc., Novogen Limited, Karyopharm Therapeutics Inc., Clovis Oncology Inc., ImmunoGen Inc., Fujirebio Diagnostics Inc., Vivesto AB
Which market trends are set to define the future of the epithelial ovarian cancer market?
Major companies operating in the epithelial ovarian cancer market are focusing on developing innovative treatment options, such as FRa-directed antibody-drug conjugates (ADCs), to specifically target folate receptor-alpha overexpressed on cancer cells, delivering potent cytotoxic agents while minimizing harm to healthy tissues. An FRa-directed antibody-drug conjugate (ADC) is a targeted cancer therapy that links an antibody specific to the folate receptor-alpha (FRa) to a cytotoxic drug, delivering the drug directly to cancer cells expressing this receptor. For instance, in November 2024, AbbVie Inc., a US-based biopharmaceutical company, received European Commission approval for ELAHERE (mirvetuximab soravtansine), a targeted treatment for adult patients with folate receptor-alpha (FRa) positive, platinum-resistant, high-grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer. ELAHERE provides a new, effective treatment option for patients who have received up to three prior systemic regimens. It targets a biomarker found in about one-third of ovarian cancer patients, enhancing the chance of survival and improving quality of life. The approval includes a companion diagnostic to identify suitable patients.
Which geographic trends are shaping the epithelial ovarian cancer market, and which region has the highest market share?
North America was the largest region in the epithelial ovarian cancer market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the epithelial ovarian cancer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Epithelial Ovarian Cancer Market Report 2025 Offer?
The epithelial ovarian cancer market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Epithelial ovarian cancer is the most common type of ovarian cancer, originating from the epithelial cells that form the outer layer of the ovary. Most often, it affects women over fifty. EOC is often asymptomatic in its early stages, leading to late diagnoses when the disease has already progressed. Symptoms, when present, may include abdominal bloating, pelvic pain, frequent urination, and changes in bowel habits.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20778
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
